Skip to main content

Table 1 Correlation between serum exosomal miR-184 expression levels in patients with NSCLC and their clinicopathological characteristics. (* p < 0.05)

From: Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer

Clinicopathological parameters

Number of patients(%)

Exosomal miR-184

Low

High

P

Age(years), Median

   

0.777

 < 60

33

15

18

 

 ≥ 60

31

13

18

 

Gender

   

0.899

 Male

28

12

16

 

 Female

36

16

20

 

Smoking history

   

0.353

 Never smoking

49

23

26

 

 Now/once smoking

15

5

10

 

ECOG Score

   

0.226

 0–1

53

25

28

 

 ≥ 2

11

3

8

 

Primary tumor

   

0.705

 ≤ 4 cm

19

9

10

 

 > 4 cm

45

19

26

 

TNM

   

0.317

 I–IVA

25

9

16

 

 IVB

39

19

20

 

PLT

   

0.411

 Low(≤ 146)

13

7

6

 

 High(> 146)

51

21

30

 

LDH

   

0.018*

 Low(≤ 199)

29

8

21

 

 High(> 199)

35

20

15

 

CEA

   

0.129

 Low(≤ 8.605)

25

8

17

 

 High(> 8.605)

39

20

19

 

Distant metastasis

   

0.164

 No

17

5

12

 

 Yes

47

23

24

 

Contralateral lung metastasis

   

0.069

 No

24

7

17

 

 Yes

40

21

19

 

Pleura metastasis

   

0.825

 No

33

14

19

 

 Yes

31

14

17

 

Bone metastasis

    

 No

23

9

14

 

 Yes

41

19

22

 

Brain metastasis

    

 No

36

14

22

 

 Yes

28

14

14

Â